准HDAC6可以改善抗CD47免疫疗法
Maria Gracia-Hernandez1, Ashutosh S Yende2, Nithya Gajendran3
1Department of Biochemistry and Molecular Medicine, The George Washington University, Washington, DC, USA.
Journal of experimental & clinical cancer research : CR
|February 28, 2024
概括
基斯脱乙酶6抑制剂 (HDAC6is) 增强巨细胞化并增强CD47免疫检查点阻塞治疗黑色素瘤. 这项研究揭示了HDAC6.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- CD47是一种免疫检查点,在癌细胞中过度表达,通过SIRPα相互作用抑制巨细胞化.
- CD47阻断在血液癌症中表现有前途,但在黑色素瘤等固体瘤中有效性有限.
- 基因组脱乙酶6抑制剂 (HDAC6is) 具有免疫调节特性,但它们在CD47/SIRPα轴中的作用尚不清楚.
研究的目的:
- 为了研究HDAC6在调节CD47/SIRPα轴和巨细胞灭菌中的作用.
- 评估HDAC6抑制与CD47阻断结合用于黑色素瘤治疗的治疗潜力.
主要方法:
- 利用骨髓衍生的巨细胞和细胞系来评估HDAC6is对巨细胞表型和细胞发生的影响.
- 通过使用小鼠和人类黑色素瘤细胞和巨细胞,研究了CD47/SIRPα轴调节和细胞.
- 对黑色素瘤小鼠模型进行了体内研究,以评估Nexturastat A与抗CD47或抗SIRPα抗体相结合的抗瘤活性.
主要成果:
- 抑制HDAC6促进了抗瘤M1巨细胞两极分化,并减少了前瘤M2表型.
- 抑制HDAC6降低了SIRPα的表达,增加了亲细胞信号,并在黑色素瘤细胞上降低了CD47的调节.
- 结合HDAC6抑制和抗CD47疗法在黑色素瘤模型中增强了巨细胞化和体内抗瘤活性.
结论:
- HDAC6在调节巨细胞和天生的免疫力方面发挥着至关重要的作用.
- HDAC6抑制剂可以强化CD47免疫检查点阻断策略用于癌症治疗.
- 使用HDAC6is和抗CD47抗体的组合治疗在黑色素瘤中显示出显著的抗瘤活性.
关键词:
CD47 CD47 CD47 CD47 CD47 CD47 CD47 CD47 CD47 CD47 CD47 CD47希斯脱乙酶的使用免疫治疗是一种免疫疗法.巨细胞是什么?巨细胞是什么?黑色素瘤是一种黑色素瘤.接下来的状态是A.发细胞症 (phagocytosis) 是一种致死细胞的发生.更多相关视频
11:06Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation
Published on: September 20, 2017
6.2K
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
8.9K
相关概念视频
01:27Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K